Á lódáil...
Combination Therapy with Paromomycin-Associated Stearylamine-Bearing Liposomes Cures Experimental Visceral Leishmaniasis through Th1-Biased Immunomodulation
Visceral leishmaniasis (VL) caused by the parasite Leishmania donovani is a potentially fatal disease. Available limited drugs are toxic, require prolonged treatment duration, and are costly. A low-cost parenteral formulation of paromomycin sulfate (PM) has recently been approved for the treatment o...
Na minha lista:
Main Authors: | , , |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
American Society for Microbiology (ASM)
2011
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3067125/ https://ncbi.nlm.nih.gov/pubmed/21220536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00524-10 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|